Pitcairn Wealth Advisors’s Amgen AMGN Stock Holding History

Pitcairn Wealth Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$817K	Hold	2,256	–	–	0.09%	126
2026 Q1	$738K	Hold	2,256	–	–	0.07%	127
2025 Q4	$738K	Buy	+2,256	New	+$716K	0.07%	129

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Pitcairn Wealth Advisors's AMGN Position: Q2 2026 in Review

Pitcairn Wealth Advisors held its Amgen (AMGN) position steady in Q2 2026 at 2,256 shares worth $817K. The position accounts for 0.09% of the portfolio, ranked #126.

Pitcairn Wealth Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Pitcairn Wealth Advisors held 2,256 shares of Amgen worth $817K as of Q2 2026.
Pitcairn Wealth Advisors left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.09% of Pitcairn Wealth Advisors's portfolio in Q2 2026, its #126 holding.
Pitcairn Wealth Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pitcairn Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.